Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Basic Materials Stocks Lagging Avino Silver (ASM) This Year?
Here is how Avino Silver (ASM) and Contango ORE, Inc. (CTGO) have performed compared to their sector so far this year.
Are Retail-Wholesale Stocks Lagging Kingfisher (KGFHY) This Year?
Here is how Kingfisher PLC (KGFHY) and MONOTARO (MONOY) have performed compared to their sector so far this year.
Are Consumer Discretionary Stocks Lagging CuriosityStream (CURI) This Year?
Here is how CuriosityStream Inc. (CURI) and Bilibili (BILI) have performed compared to their sector so far this year.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Construction Stocks Lagging Granite Construction (GVA) This Year?
Here is how Granite Construction (GVA) and Trane Technologies (TT) have performed compared to their sector so far this year.
Bristol Myers Squibb (BMY) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Oxford Square Capital (OXSQ) Loses 7.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Oxford Square Capital (OXSQ) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)
The heavy selling pressure might have exhausted for P3 Health Partners (PIII) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.